29th Annual North American Cystic Fibrosis Conference

S09: CFTR-NT: Developing Co-therapies to Modulate CFTR

Oct 9, 2015 10:30am ‐ Oct 9, 2015 12:20pm

Standard: $49.99


This session will highlight the issues around co-therapies from the clinical to the development.

Educational Objectives:

  1. Discuss the need for co-therapies in CF for different combinations of CFTR mutations & the benefits & disadvantages of co-therapies.
  2. Analyze how to screen for additive/synergistic drugs.
  3. Demonstrate how to assess benefit of CF co-therapies.


You must be logged in and own this session in order to post comments.